IGF-1 LR3: What It Is and What It Does

What IGF-1 LR3 is

IGF-1 LR3 is a tweaked, longer-lasting version of a natural growth factor called insulin-like growth factor 1. It is supplied as an analytical-grade reference material for laboratory research.

Where it comes from

IGF-1 LR3 (Long R3 IGF-1) is an engineered version of insulin-like growth factor 1, a natural growth factor closely related to insulin. It was designed in the 1990s as a research reagent with two changes to the natural protein: a 13-amino-acid extension added to one end, and a single amino-acid swap (arginine in place of glutamate at position 3). Together these greatly weaken its grip on the IGF-binding proteins that normally sequester IGF-1 — so the 'LR3' form stays free and active far longer in culture, which is exactly what made it useful in the lab.

What it does — in plain terms

IGF-1 is one of the body's main 'grow and multiply' signals for cells. The 'LR3' version is engineered to stay active much longer in lab conditions, which makes it convenient for experiments. In cell-culture research it's used to study how cells grow, divide, and respond to growth signals — it's a common tool for keeping cells growing steadily in a dish.

How it works

IGF-1 is one of the body's central 'grow and multiply' signals. It binds the IGF-1 receptor on the cell surface and switches on the internal pathways (such as PI3K/Akt) that drive cells to take up nutrients, grow, divide, and resist programmed death. In the body, most IGF-1 does not float free — it rides around bound to IGF-binding proteins (IGFBPs), which act as reservoirs and brakes, releasing it only where and when it is needed.

The 'LR3' modifications are aimed squarely at those binding proteins. By adding an N-terminal extension and swapping a single amino acid, the engineered protein binds the IGFBPs much more weakly, so it escapes their control and stays available to hit the IGF-1 receptor. That is why LR3 is markedly longer-acting than plain IGF-1 in a culture dish, and why it is a convenient, steady growth stimulus for experiments.

That same binding-protein biology is a recurring theme in the literature: several studies look at how IGF-1, its receptor, and the IGFBPs interact — in animals, in cell culture, and in disease-model contexts. The engineered LR3 form is essentially a tool for asking what IGF-1 signaling does when the usual binding-protein brakes are released.

What the research shows

It is important to be clear up front: the IGF-1 LR3 literature is overwhelmingly preclinical — animal studies (cattle, pigs, guinea pigs, mice), plus cell-culture and protein-engineering work — with no human clinical trials of the modified protein behind it. Its main role is as a laboratory reagent and a probe of IGF-1 biology, not as a studied therapy in people. With that clearly in mind, here is what the provided work reports.

• Journal of Alzheimer's Disease, 2025 — examined IGF-1 LR3 in a mouse model of amyloid plaque pathology, probing how sustained IGF-1 signaling affects the brain.
• Domestic Animal Endocrinology, 1999 — studied how IGF-1 LR3 affected protein metabolism in cattle, an animal model of growth signaling.
• Applied Microbiology and Biotechnology, 2023 — reported methods for producing recombinant IGF-1 LR3, work aimed at expressing and purifying the engineered protein.
• The Journal of Endocrinology, 1997 — measured the effect of IGF-1 LR3 on growth markers in pigs, tracking readouts of the growth-signaling axis.
• Growth Factors, 1996 — described IGF-1 LR3 muteins in a protein-design study, exploring how sequence changes alter the growth factor's behavior.
• Growth Factors, 2002 — investigated the intestinal absorption of IGF-1 LR3, relevant to how the modified protein crosses biological barriers.
• The Journal of Endocrinology, 1995 — examined how IGF-1 LR3 influenced organ growth in guinea pigs, an animal model of IGF-driven tissue growth.
• Endocrine, 1998 — studied IGF-1's role in bone-marrow cell development in mice, part of the broader picture of IGF signaling in cell growth.
• Oncogene, 2007 — explored the mechanism linking IGF-binding protein-3 to prostate cancer, illustrating how the IGFBP side of the system influences cell behavior.
• Endocrinology, 1992 — studied IGF and IGF-binding proteins in ovarian cells, characterizing how binding proteins modulate IGF activity.

What IGF-1 LR3 is studied for

IGF-1 receptor signaling. The engineered protein binds the IGF-1 receptor and switches on the growth-and-survival pathways (like PI3K/Akt) that drive cells to grow and divide — the core reason it is used as a steady growth stimulus.

Escaping the binding proteins. The 'LR3' changes weaken its grip on IGF-binding proteins, so it stays free and active far longer than natural IGF-1 — the feature that makes it convenient in cell culture.

A cell-culture and research reagent. Much of its use is practical: keeping cells growing steadily in a dish, and serving as a probe for what IGF-1 signaling does under controlled conditions.

IGF biology in animal models. Studies in cattle, pigs, and guinea pigs used IGF-1 LR3 to examine protein metabolism, growth markers, and organ growth — classic readouts of the IGF axis.

Storage & handling

As a lyophilized powder, IGF-1 LR3 reference material keeps best cold and dark — refrigerated for short-term storage, frozen for longer holds. Once reconstituted with bacteriostatic water it should be refrigerated at roughly 2–8 °C, protected from light, and shielded from repeated freeze-thaw cycles, which are especially hard on a larger protein like this one. See the reconstitution reference below for the concentration math. Supplied for laboratory research use only.

Reconstitution reference

Standard laboratory reconstitution volumes for IGF-1 LR3, from the VNG Reconstitution Sheet. See the full reconstitution guide for the method and concentration math.